Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Treatment With the Oral Iron Chelator Deferiprone on the Oxidative Stress of Blood Cells and on Iron Overload Status in Transfusion Dependent, Iron-overloaded Patients With Low Risk Myelodysplastic Syndrome

NCT02477631 is registered in ClinicalTrials.gov with Sheba Medical Center as lead sponsor.

NCT NCT02477631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02477631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Treatment With the Oral Iron Chelator Deferiprone on the Oxidative Stress of Blood Cells and on Iron Overload Status in Transfusion Dependent, Iron-overloaded Patients With Low Risk Myelodysplastic Syndrome
Lead sponsor
Sheba Medical Center
Phase
Phase 2
Overall status
Completed
Start date
February 29, 2016
Completion date
June 30, 2018
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

iron overload due to repeated red blood cell transfusions, myelodysplastic syndrome with low-grade lesions